期刊文献+

游动放线菌产雷帕霉素的发酵工艺改进 被引量:4

Improvement of Fermentation Technology of Rapamycin by Actinoplanes sp.
原文传递
导出
摘要 以游动放线菌Actinoplanes sp.SIPI-8011为出发菌株,通过优化其发酵培养基组分及含量,促进雷帕霉素的合成。结果显示,培养基中添加甘油作为碳源,并分阶段控制pH值,能够提高雷帕霉素产量,而添加甜菜碱能够减少副产物27-O-去甲基雷帕霉素的生成。于50 L发酵罐上进行放大培养,结果显示,在优化工艺下,50 L发酵罐中雷帕霉素的产量为920ug/ml,比原工艺提高了38.8%,27-O-去甲基雷帕霉素含量较优化前减少了83.5%。 The fermentation medium composition was optimized in flasks to improve the production of rapamycin by Actinoplanes sp. SIPI-8011. The results showed that it could increase the productivity of rapamycin by adding glycerol as the carbon resource, as well as controlling pH value during the period. Meanwhile, it could reduce the formation of the byproduct 27-O-demethylrapamycin by adding betaine. The improved medium was investigated in a 50 L jar-fermentor, and the titre of rapamycin reached 920 μg/ml, which was a 38.8 % increase compared to the original conditions. The amount of 27-O-demethylrapamycin was reduced by 83.5 % at the same time.
出处 《中国医药工业杂志》 CAS CSCD 北大核心 2014年第10期925-928,共4页 Chinese Journal of Pharmaceuticals
基金 国家"重大新药创制"科技重大专项(2014ZX09201001-012) 上海市科技支撑项目(12431901102)
关键词 免疫抑制剂 雷帕霉素 27-O-去甲基雷帕霉素 发酵 immunosuppressant rapamycin 27-O-demethylrapamycin fermentation
  • 相关文献

参考文献7

二级参考文献43

  • 1杜平中.两种新型大环内酯类免疫抑制剂[J].中国医药工业杂志,1995,26(7):330-333. 被引量:5
  • 2吴洪涛,刘任.新型免疫抑制剂FK506在器官移植中的应用进展[J].国外医学(泌尿系统分册),1996,16(1):28-30. 被引量:4
  • 3程元荣,郑卫.新分子靶位mTOR与新抗肿瘤靶向药物雷帕霉素[J].中国处方药,2006,5(12):16-19. 被引量:12
  • 4Camardo J. The Rapamune era of immunosuppression 2003 : the journey from the laboratory to clinical transplantation [ J]. Transplant Proc, 2003, 35 (Suppl 3A) : 18S -24S.
  • 5Weischer M, Rocken M, Berneburg M. Calcineurin inhibitors and rapamycin: cancer protection or promotion [ J ]. Exo Dermatol, 2007, 16(5) : 385 -393.
  • 6Andrassy J, Graeb C, Rentsch Met al. roTOR inhibition and its effect on cancer in transplantation [ J ]. Transplantation, 2005, 80(1 Suppl) : S171 - S174.
  • 7Albanell J, Dalmases A, Rovira A, Rojo F. roTOR signalling in human cancer [ J ]. Clin Transl Oncol, 2007, 9 (8) : 484 - 493.
  • 8Zeiser R, Nguyen VH, Beilhack A et al. Inhibition of CD4 ^+CD25^+ regulatory T-cell function by calcineurin-dependent interleukin-2 production [ J ]. Blood, 2006, 108 ( 1 ) : 390 - 399.
  • 9Breslin EM, White PC, Shore AM et al. LY294002 and rapamycin co-operate to inhibit T-cell proliferation [ J]. Br J Pharmacol, 2005, 144 (6) : 791 - 800.
  • 10Battaglia M, Stabilini A, Roncarolo MG. Rapamycin selectively expands CD4^+ CD25^+ FoxP3^ + regulatory T cells [J]. Blood, 2005, 105(12): 4743 -4748.

共引文献10

同被引文献27

引证文献4

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部